Solve CEO Emily Taylor Co-Authors RECOVER Study On Risk of Developing ME/CFS After COVID
Solve CEO Emily Taylor and co-authors from esteemed organizations including the Bateman Horne Center; New York University; the Patient Led Research Collaboration on COVID-19; the University of California, San Francisco; […]
Hope Amid Uncertainty
A special message from Solve M.E. President and CEO Emily Taylor With so much speculation about the future, it’s easy to feel unsettled – and uncertainty is especially hard for […]
The Future of IACCI and Long Covid Research: ME/CFS and the Unfinished work of the COPVS Task Force
**NEW TIME AND DATE!** In 2021 the National Institutes of Health (NIH) launched the RECOVER Initiative, a patient-centered, integrated, adaptive research network created to study Long Covid. Included in the […]
Solve CEO Emily Taylor Calls for More Research Funding, New NIH Office in “Open Access Government”
Solve President and CEO Emily Taylor recently penned an op-ed piece for Open Access Government calling for more funding and multidisciplinary collaboration for research of ME/CFS, Long Covid, and other […]
Solve Author Series: Dr. Peter Rowe Discusses “Living Well with Orthostatic Intolerance: A Guide to Diagnosis and Treatment”
Orthostatic intolerance (OI) describes a group of circulatory disorders whose symptoms are characterized by a dramatic drop in blood flow to the brain when people are sitting for long periods […]
Solve Leadership Honors Top Immunologist and Presents Solve Together Real-World Data Platform
Solve CSO Tim Hsiao, Director of Advancement Ilise Friedman, Dr. Akiko Iwasaki, and Solve President Emily Taylor Solve President and CEO Emily Taylor, Chief Scientific Officer H. Timothy Hsiao, and […]
Key Takeaways from NASEM’s “Long Term Health Effects of COVID-19: Disability and Function Following SARS-COV-2 Infection” Report
The National Academies of Sciences, Engineering, and Medicine (NASEM), a nongovernmental institution that advises federal agencies on science and medicine, has released its report, “Long Term Health Effects of COVID-19: […]
Solve M.E. Announces Emily Taylor as New President and CEO and Publication of New White Paper Calling for NIH to Restructure Funding for ME/CFS, Long Covid, and other IACCIs
Solve M.E. is pleased to announce that Emily Taylor, Vice President of Advocacy and Engagement, has been appointed as President and CEO. Emily has been a key member of Solve’s […]
Solve Releases New White Paper: A Home for Infection-Associated Chronic Conditions and Illnesses (IACCIs) at NIH
Complementing our Advocacy Week 2024 efforts, Solve has co-authored a new white paper, “A Home for Infection-Associated Chronic Conditions and Illnesses (IACCIs) at NIH.” Co-written by Solve President and CEO […]
Solve VP of Advocacy Emily Taylor talks to STAT About the Push For a New Coordinating Mechanism at NIH for Infection-Associated Chronic Conditions
On March 15, Long Covid Awareness Day, Solve’s VP of Advocacy and Engagement Emily Taylor was quoted by STAT in its coverage of the push for a new office at […]
Susannah Fox Will be the Keynote Speaker for Solve’s 2024 EmPOWER M.E. Event
As part of Advocacy Week 2024, our EmPOWER M.E. roundtable on April 19 at 9 am PT / 12 pm ET will feature panels of patient advocates, professionals, and scientists […]
Solve Responds to Findings From the NIH Intramural ME/CFS Clinical Study Published in “Nature”
Findings from the National Institutes of Health (NIH) intramural ME/CFS clinical study were published in Nature Communications last week to mixed reception by the patient advocate community. Co-written by 75 […]
